Lysine acetyltransferases (KATs) are an important class of enzymes responsible for acetylating lysine residues on histones and other proteins. This modification contributes to gene-expression regulation, protein function, and chromatin dynamics. Dysregulated KAT activity has been implicated in cancer, neurodegenerative disorders, and inflammatory conditions.
Targeting KATs with selective inhibitors may help modulate abnormal acetylation patterns and restore disease-relevant cellular functions.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Get a quote
Go top